Insider Transactions Reported by 18 Insiders of TITAN PHARMACEUTICALS INC

Symbol
TTNP
Location
San Francisco, CA

Sponsored

There are no Buy or Sell transactions made by insiders since 04 Apr 2025

TITAN PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Sire Group Ltd. 10%+ Owner $25,628,607 Mixed 13 Sep 2023
Choon Choong Hau 10%+ Owner $4,676,583 Mixed 18 Mar 2024
David E. Lazar Chief Executive Officer, Director $123,000 Mixed 26 Jul 2023
Katherine Beebe DeVarney President and COO, Director $81,488 Mixed 25 Oct 2023
Matthew Charles McMurdo Director $81,488 Mixed 25 Oct 2023
Eric Howard Greenberg Director $81,488 Mixed 25 Oct 2023
David Natan Director $81,488 Mixed 25 Oct 2023
James R. McNab Director $64,809 Mixed 28 Jan 2022
Peter L. Chasey Director $61,500 Mixed 26 Jul 2023
Avraham Ben-Tzvi Director $0 Mixed 01 Oct 2025
Francisco Osvaldo Flores Garcia Director $0 Mixed 02 Apr 2024
Firdauz Mokhtar Director $0 Mixed 02 Apr 2024
Chay Weei Jye Chief Executive Officer $0 Mixed 20 Mar 2025
Gabriel Loh Director $0 Mixed 27 Mar 2025
Marc Rubin Executive Chairman, Director Mixed 05 Jan 2022
Joseph A. Akers Director Mixed 05 Jan 2022
Brynner Chiam Director Mixed 12 Oct 2023
M. David Macfarlane Director Mixed 05 Jan 2022

Recent Insider Transactions by Companies or Individuals for TITAN PHARMACEUTICALS INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Avraham Ben-Tzvi TTNP Common Stock Disposed to Issuer -100% -3,313 0 01 Oct 2025 Direct
Avraham Ben-Tzvi TTNP Option to Purchase Common Stock Disposed to Issuer -100% -6,250 0 01 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.